• Je něco špatně v tomto záznamu ?

Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine

M. Douša, J. Srbek, S. Rádl, J. Cerný, O. Klecán, J. Havlíček, M. Tkadlecová, T. Pekárek, P. Gibala, L. Nováková,

. 2014 ; 94 (-) : 71-6.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008292

Two new impurities were described and determined using gradient HPLC method with UV detection in retigabine (RET). Using LC-HRMS, NMR and IR analysis the impurities were identified as RET-dimer I: diethyl {4,4'-diamino-6,6'-bis[(4-fluorobenzyl)amino]biphenyl-3,3'-diyl}biscarbamate and RET-dimer II: ethyl {2-amino-5-[{2-amino-4-[(4-fluorobenzyl) amino] phenyl} (ethoxycarbonyl) amino]-4-[(4-fluorobenzyl)amino] phenyl}carbamate. Reference standards of these impurities were synthesized followed by semipreparative HPLC purification. The mechanism of the formation of these impurities is also discussed. An HPLC method was optimized in order to separate, selectively detect and quantify all process-related impurities and degradation products of RET. The presented method, which was validated in terms of linearity, limit of detection (LOD), limit of quantification (LOQ) and selectivity is very quick (less than 11min including re-equilibration time) and therefore highly suitable for routine analysis of RET related substances as well as stability studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008292
003      
CZ-PrNML
005      
20150327120014.0
007      
ta
008      
150306s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2014.01.042 $2 doi
035    __
$a (PubMed)24552644
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Douša, Michal $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz.
245    10
$a Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine / $c M. Douša, J. Srbek, S. Rádl, J. Cerný, O. Klecán, J. Havlíček, M. Tkadlecová, T. Pekárek, P. Gibala, L. Nováková,
520    9_
$a Two new impurities were described and determined using gradient HPLC method with UV detection in retigabine (RET). Using LC-HRMS, NMR and IR analysis the impurities were identified as RET-dimer I: diethyl {4,4'-diamino-6,6'-bis[(4-fluorobenzyl)amino]biphenyl-3,3'-diyl}biscarbamate and RET-dimer II: ethyl {2-amino-5-[{2-amino-4-[(4-fluorobenzyl) amino] phenyl} (ethoxycarbonyl) amino]-4-[(4-fluorobenzyl)amino] phenyl}carbamate. Reference standards of these impurities were synthesized followed by semipreparative HPLC purification. The mechanism of the formation of these impurities is also discussed. An HPLC method was optimized in order to separate, selectively detect and quantify all process-related impurities and degradation products of RET. The presented method, which was validated in terms of linearity, limit of detection (LOD), limit of quantification (LOQ) and selectivity is very quick (less than 11min including re-equilibration time) and therefore highly suitable for routine analysis of RET related substances as well as stability studies.
650    _2
$a karbamáty $x chemie $7 D002219
650    _2
$a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
650    _2
$a kontaminace léku $7 D004340
650    _2
$a stabilita léku $7 D004355
650    _2
$a limita detekce $7 D057230
650    _2
$a fenylendiaminy $x chemie $7 D010655
650    _2
$a referenční standardy $7 D012015
655    _2
$a časopisecké články $7 D016428
700    1_
$a Srbek, Jan $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Rádl, Stanislav $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Cerný, Josef $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Klecán, Ondřej $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Havlíček, Jaroslav $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Tkadlecová, Marcela $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Pekárek, Tomáš $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Gibala, Petr $u Zentiva, k.s. Praha, U Kabelovny 130, 102 37 Praha 10, Czech Republic.
700    1_
$a Nováková, Lucie $u Department of Analytical Chemistry, Charles University, Faculty of Pharmacy, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 94, č. - (2014), s. 71-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24552644 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150327120336 $b ABA008
999    __
$a ok $b bmc $g 1065565 $s 891092
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 94 $c - $d 71-6 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...